Literature DB >> 9452300

Simplified polymerase chain reaction detection of new world Leishmania in clinical specimens of cutaneous leishmaniasis.

A Belli1, B Rodriguez, H Aviles, E Harris.   

Abstract

Polymerase chain reaction (PCR)-based detection of New World Leishmania from different types of clinical specimens has been further streamlined for field use by simplifying sample preparation and modifying published protocols. A multiplex PCR reaction was developed that allows simultaneous detection of the Leishmania genus and identification of the L. braziliensis complex. For typing isolates in culture, we found that simply boiling diluted cultured strains was sufficient preparation for the PCR. We have demonstrated that Leishmania parasites can be reliably detected from boiled dermal scrapings, instead of the more invasive skin biopsies often used as PCR specimens. The PCR of dermal scrapings yielded a sensitivity of 100% and a specificity of 100%, as compared with microscopic examination. In a study population, PCR was more sensitive than classic diagnostic techniques. The PCR detection of Leishmania in biopsies and peripheral blood mononuclear cells (PBMCs) was investigated. Diluting crude extracts of skin biopsies was sufficient to eliminate sample inhibition yet maintain required sensitivity. Leishmania braziliensis was also detected by PCR in PBMCs of individuals with active cutaneous leishmaniasis. The simplifications described here significantly improve the feasibility of using the PCR in endemic countries as the primary method for detection and preliminary characterization of Leishmania in clinical specimens of cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452300     DOI: 10.4269/ajtmh.1998.58.102

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

Review 1.  Multiplex PCR: optimization and application in diagnostic virology.

Authors:  E M Elnifro; A M Ashshi; R J Cooper; P E Klapper
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Health technology transfer.

Authors:  E Harris; M Tanner
Journal:  BMJ       Date:  2000-09-30

3.  Use of PCR to detect Leishmania (Viannia) spp. in dog blood and bone marrow.

Authors:  R Reithinger; B E Lambson; D C Barker; C R Davies
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Building scientific capacity in developing countries.

Authors:  Eva Harris
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

Review 5.  Innovative low cost technologies for biomedical research and diagnosis in developing countries.

Authors:  Josefina Coloma; Eva Harris
Journal:  BMJ       Date:  2004-11-13

6.  PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia).

Authors:  Kristen A Weigle; Luz Angela Labrada; Caterin Lozano; Cecilia Santrich; Douglas C Barker
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Prospective value of PCR amplification and sequencing for diagnosis and typing of old world Leishmania infections in an area of nonendemicity.

Authors:  Jean-Pierre Gangneux; Jean Menotti; Frédéric Lorenzo; Claudine Sarfati; Hélène Blanche; Hung Bui; Francine Pratlong; Yves-Jean-François Garin; Francis Derouin
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

8.  New PCR assay using glucose-6-phosphate dehydrogenase for identification of Leishmania species.

Authors:  Tiago M Castilho; Jeffrey Jon Shaw; Lucile M Floeter-Winter
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR.

Authors:  E Harris; T G Roberts; L Smith; J Selle; L D Kramer; S Valle; E Sandoval; A Balmaseda
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Molecular genomic approaches to infectious diseases in resource-limited settings.

Authors:  Josefina Coloma; Eva Harris
Journal:  PLoS Med       Date:  2009-10-26       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.